• Salama Alan D
• Womer Karl L
• Sayegh Mohamed H

Journal of immunology (Baltimore, Md. : 1950)

• Publish Date: May 2007
• ISSN: 0022-1767
• Volume: 178
• Issue: 9
• Pages: 5419-23
• Medium: Print
• Language: English
• Citation (JAMA): Salama Alan D, Womer Karl L, Sayegh Mohamed H, et al. Clinical Transplantation Tolerance: Many Rivers to Cross.. J. Immunol. May 2007;178:5419-23

Abstract

Modern immunosuppressive regimens for organ transplantation have resulted in excellent short-term results but less dramatic improvements in long-term outcomes. Moreover, they are associated with significant deleterious effects. One solution that should avoid the adverse drug effects and result in improved graft and patient longevity as well as positively impacting on the organ shortage is the establishment of transplantation tolerance. Ever since the original description of transplantation tolerance in rodent allografts, there have been significant efforts made to translate tolerance-promoting strategies to the clinical arena. However, >50 years later, we are still faced with significant barriers that are preventing such a goal from being widely attained. Nonetheless, pilot clinical tolerance protocols are underway in selected transplant recipients. In this review, we discuss the scientific and nonscientific issues that must be overcome for successful transplantation tolerance to become a clinical reality.

This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.